EBRO 2017

ACCORD 12/0405-Prodige 2

Cap45 Capox50

p value

pCR

13.9% 19.2% 0.09

Sphincter sparing

74.6% 75.4%

Local recurrence

6.1% 4.4%

Overall survival 87.6% 88.3% Acute G3-4 diarrhoea 3.2% 12.6% <0.001

Gerard JP, J Clin Oncol. 2010 Apr 1;28(10):1638-44